Major Goals: To evaluate the effect of six months of treatment with udenafil on exercise capacity in adolescents with Fontan physiology.2019-12-31NHLBI (PHN)Paridon, Stephen2015-07-01Fontan Udenafil Exercise Longitudinal (FUEL) Assessment Trial1 U10 HL068270cmhprofilesont:personsuffixperson suffixprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasFacultyRankhas faculty rankprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:principalInvestigatorNameprincipal investigator nameprns:sortOrdersort orderprns:startDatestart datebibo:abstractabstractAgreementvivo:contributingRolecontributorDepartmentDivisionGrantvivo:hrJobTitleHR job titlevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:typetyperdfs:labellabelAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson2Associate ProfessorPediatricsClinicalChildren's Mercy Kansas CityDOJonathanWagnerJonathan B. Wagner0.000000000000000.00000000000000183Wagner, Jonathan0000000176906798Physician and Interim Division Director, Clinical Pharmacology, Toxicology & Therapeutic InnovationSite Primary Investigatortrue1Physician and Interim Division Director, Clinical Pharmacology, Toxicology & Therapeutic InnovationPhysician and Interim Division Director, Clinical Pharmacology, Toxicology & Therapeutic Innovation